1.
Davis SM,
Donnan GA,
Parsons MW,
Levi C,
Butcher KS,
Peeters A,
et al; EPITHET Investigators.
Effects of alteplase beyond 3 h after stroke
in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.
Lancet Neurol.
2008;7:299–309.
2.
Albers GW,
Thijs VN,
Wechsler L,
Kemp S,
Schlaug G,
Skalabrin E,
et al; DEFUSE Investigators.
Magnetic resonance imaging profiles predict
clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study.
Ann Neurol. 2006;60:508–517.
3.
Lansberg MG,
Straka M,
Kemp S,
Mlynash M,
Wechsler LR,
Jovin TG,
et al; DEFUSE 2 Study Investigators.
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study.
Lancet Neurol.
2012;11:860–867.
4.
Bang OY,
Saver JL,
Buck BH,
Alger JR,
Starkman S,
Ovbiagele B,
et al; UCLA Collateral Investigators.
Impact of collateral flow on tissue fate in acute ischaemic stroke.
J Neurol Neurosurg Psychiatry.
2008;79:625–629.
5.
Bang OY,
Saver JL,
Kim SJ,
Kim GM,
Chung CS,
Ovbiagele B,
et al.
Collateral flow predicts response to endovascular therapy for acute ischemic stroke.
Stroke.
2011;42:693–699.
6.
Bang OY,
Saver JL,
Kim SJ,
Kim GM,
Chung CS,
Ovbiagele B,
et al; UCLA-Samsung Stroke Collaborators.
Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke.
Stroke.
2011;42:2235–2239.
7.
Straka M,
Albers GW,
Bammer R.
Real-time diffusion-perfusion mismatch analysis in acute stroke.
J Magn Reson Imaging.
2010; 32:1024–1037.
8.
Olivot JM,
Mlynash M,
Thijs VN,
Kemp S,
Lansberg MG,
Wechsler L,
et al.
Optimal Tmax threshold for predicting penumbral tissue in acute
stroke.
Stroke.
2009;40:469–475.
9.
Lansberg MG,
Lee J,
Christensen S,
Straka M,
De Silva DA,
Mlynash M,
et al.
RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study.
Stroke.
2011;42:1608–1614.
10.
Hacke W,
Kaste M,
Fieschi C,
Toni D,
Lesaffre E,
von Kummer R,
et al.
Intravenous thrombolysis with recombinant tissue plasminogen activator
for acute hemispheric stroke.
The European Cooperative Acute Stroke Study (ECASS).
JAMA.
1995;274:1017–1025.
11.
Higashida RT,
Furlan AJ,
Roberts H,
Tomsick T,
Connors B,
Barr J,
et al; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Stroke.
2003;34:e109–e137.
12.
Zaidat OO,
Yoo AJ,
Khatri P,
Tomsick TA,
von Kummer R,
Saver JL,
et al; Cerebral Angiographic Revascularization Grading (CARG) Collaborators; STIR Revascularization Working Group; STIR Thrombolysis in Cerebral Infarction (TICI) Task Force.
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.
Stroke.
2013;44:2650–2663.
13.
Campbell BC,
Christensen S,
Tress BM,
Churilov L,
Desmond PM,
Parsons MW,
et al; EPITHET Investigators.
Failure of collateral blood flow is associated with infarct growth in ischemic stroke.
J Cereb Blood Flow Metab.
2013;33:1168–1172.
14.
Ribo M,
Flores A,
Rubiera M,
Pagola J,
Sargento-Freitas J,
Rodriguez- Luna D,
et al.
Extending the time window for endovascular procedures according to collateral pial circulation.
Stroke.
2011;42:3465–3469.